July 24, 2014 5:10 PM ET

Capital Markets

Company Overview of Novartis Venture Funds

Company Overview

Novartis Venture Funds is a venture capital arm of Novartis AG specializing in investments in early startup companies and Series A investment. The firm also makes early, mid and late venture investments. It seeks to invest in biotech and life sciences companies with a focus on new novel therapeutics and platforms; medical devices and implants; diagnostics and biomarkers; and drug delivery and biopolymers. The firm primarily invests in private and public companies based in the United States, Canada, Europe, Switzerland, and Asia Pacific. It seeks to invest between $15 million and $20 million per company over its life, but it can be as little as $0.1 million to get started. The firm invests th...

Forum 1-3.73

P.O. Box

Basel,  CH-4002

Switzerland

Founded in 1996

Phone:

41 61 324 32 67

Fax:

41 61 324 86 79

Key Executives for Novartis Venture Funds

Global Head and Executive Director
Managing Director
Managing Director
Age: 37
Managing Director
Managing Director
Compensation as of Fiscal Year 2014.

Novartis Venture Funds Key Developments

Novartis Venture Funds Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-14-2014 10:10 AM

Novartis Venture Funds Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-14-2014 10:10 AM. Venue: London, United Kingdom. Speakers: Anja König, Managing Director.

Novartis Venture Funds Presents at 7th Annual European Life Sciences CEO Forum, Mar-04-2014 09:20 AM

Novartis Venture Funds Presents at 7th Annual European Life Sciences CEO Forum, Mar-04-2014 09:20 AM. Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Speakers: Markus Goebel, Managing Director, Partner.

Novartis Venture Funds Presents at 2013 Therapeutic Area Partnerships Conference, Nov-20-2013 08:45 AM

Novartis Venture Funds Presents at 2013 Therapeutic Area Partnerships Conference, Nov-20-2013 08:45 AM. Venue: One Avenue De Lafayette, Boston, MA 02111, United States. Speakers: Lauren Silverman, Managing Director.

Similar Private Companies By Industry

Company Name Region
Wineus AG, advisory arm Europe
Soneva S.A., Advisory Arm Europe
Swiss Capital Wealth Management AG Europe
Merrill Lynch Derivative Products AG Europe
Oppenheimer Investments AG Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 9, 2014
Idenix Pharmaceuticals Inc.
Private Placement
May 7, 2014
ImaginAb, Inc.
Private Placement
May 5, 2014
Anokion SA
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novartis Venture Funds, please visit www.venturefund.novartis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.